Products

Nextmol is a cloud-based computational chemistry platform designed to accelerate the development of new materials and chemicals. By leveraging advanced molecular modeling and simulation techniques, Nextmol enables researchers and scientists to predict the properties and behavior of molecules, facilitating the design of innovative products across various industries.

Nabla Bio is a biotechnology company specializing in the de novo design of antibody therapeutics through the integration of artificial intelligence (AI) and experimental technologies. Founded by experts from George Church's Lab at Harvard, Nabla Bio combines generative AI models with large-scale multiplex experiments to engineer protein-based therapies, particularly targeting applications where traditional discovery methods have been less effective.

Reshape Biotech offers an AI-powered platform that automates the imaging and analysis of petri and microtiter plates, enabling laboratories to capture high-resolution images, extract data instantly, and obtain reliable results.

CellVoyant is an AI-first biotechnology company dedicated to accelerating the development of life-changing therapies aimed at curing chronic diseases. By integrating advanced artificial intelligence with live cell imaging, CellVoyant predicts and optimizes stem cell differentiation processes. This innovative approach enables precise cell analytics and process development, facilitating the scalable and controllable manufacturing of any cell or tissue type within the human body. Operating at the i

Yoneda Optimize is a desktop application developed by Yoneda Labs, designed to assist chemists in optimizing chemical reactions efficiently. By leveraging advanced statistical and machine learning algorithms, it enables users to identify optimal reaction conditions, such as temperature, concentration, and catalyst selection, thereby enhancing yield and reducing costs. This tool is particularly beneficial when traditional methods are insufficient or when experimental data is limited.

AQChemSim is an advanced computational platform developed by SandboxAQ that revolutionizes the discovery and optimization of chemicals and materials. By integrating Large Quantitative Models (LQMs) derived from artificial intelligence and physics-based methodologies, AQChemSim accelerates innovation across various industries, including catalyst development, battery technology, and alloy design. This approach offers a groundbreaking alternative to traditional materials discovery by combining data

LIMS Digital is a Unified SaaS-based Laboratory Software Suite designed to revolutionize laboratory operations across diverse sectors. Built to meet the complex needs of Medical and Diagnostic Laboratories, Biorepositories, Environmental Labs, and the Cannabis Industry, LIMS Digital delivers scalable, secure, and fully customizable solutions. Whether you're focused on Clinical Diagnostics, managing sample workflows, or ensuring regulatory compliance, LIMS Digital simplifies every stage—from sam

ReactWise Collaborate is a specialized solution designed to enhance teamwork and communication within chemical process optimization projects. By providing shared dashboards and real-time data access, it ensures seamless collaboration among chemists, engineers, and management. This platform facilitates efficient interaction with external partners, promoting continuous knowledge transfer and streamlined project execution.

Albert Invent's Inventory module is a comprehensive digital solution designed to modernize laboratory inventory management. It offers real-time tracking of materials across multiple locations, ensuring compliance and safety through instant visibility. The system generates detailed reports on hazardous materials, lot-to-lot tracking, and inventory movements, facilitating rapid root cause analysis when issues arise. Automatic alerts notify users of low stock levels, compliance requirements, and ma

Albert Invent's Electronic Lab Notebook (ELN) is a comprehensive digital solution designed to streamline chemistry workflows by integrating essential laboratory functions into a single, user-friendly platform. It offers chemists an intuitive interface to document experiments, manage data, and collaborate effectively, enhancing productivity and innovation in research and development.

Albert Invent's Laboratory Information Management System (LIMS) is designed to unify and streamline laboratory data management, facilitating seamless experimentation and analysis. By standardizing data capture and integrating with laboratory instruments, it enhances efficiency and ensures consistency across research teams.

Nanite is a pioneering biotechnology company specializing in the development of non-viral gene delivery systems. Their proprietary platform, SAYER™, integrates artificial intelligence with high-throughput experimental and computational methods to design programmable polymer nanoparticles (PNPs). These PNPs are engineered to deliver a wide range of genetic cargoes with tissue specificity, offering a safer and more efficient alternative to traditional viral vectors. By harnessing AI-driven design,

PolyModels Hub is a British software startup specializing in SaaS solutions for pharmaceutical process development. Their platform leverages artificial intelligence to assist scientists in modeling, simulating, and gaining insights across all protocols involved in transforming chemical compounds into safe drug products.

AQBioSim, developed by SandboxAQ, is an advanced platform that revolutionizes drug discovery and development by integrating artificial intelligence (AI) and quantum-inspired technologies. This comprehensive solution employs Large Quantitative Models (LQMs) to simulate molecular interactions, enabling precise predictions of drug compound behaviors. By accelerating the identification and optimization of both small molecules and biologics, AQBioSim significantly reduces research and development tim

Lila Sciences is pioneering the world's first scientific superintelligence platform, integrating artificial intelligence with autonomous laboratories to revolutionize life, chemical, and materials sciences. By placing AI at the core of scientific discovery, Lila aims to rapidly expand human knowledge and address humanity's most pressing challenges.

Terray Therapeutics is a biotechnology company revolutionizing small molecule drug discovery by integrating ultra-high throughput experimentation with generative AI. Their proprietary tNova platform combines precise chemical data generation with advanced computational analysis, enabling the rapid identification and optimization of novel therapeutics. This approach accelerates the drug development process, reduces costs, and enhances success rates, addressing complex therapeutic challenges across

CellChorus offers dynamic single-cell analysis through its TIMING™ (Time-lapse Imaging Microscopy in Nanowell Grids) platform, which utilizes visual AI to evaluate how thousands of individual cells move, activate, interact, kill, and survive over time. This technology provides a comprehensive understanding of cellular function, state, and phenotype, surpassing traditional methods that often lack the ability to integrate dynamic cellular behavior with molecular insights at the single-cell level.

Biolevate is a pioneering company dedicated to integrating ethical artificial intelligence (AI) into the healthcare sector, aiming to create simple, secure, and collaborative solutions that accelerate medical advancements for a more accessible world. By harnessing the power of AI, Biolevate addresses the complex challenges faced by the life sciences industry, offering tailored solutions that enhance efficiency, compliance, and innovation.

Talus Bio is a biotechnology company specializing in the discovery and development of therapeutics targeting previously undruggable transcription factors—proteins that regulate gene expression and are implicated in various diseases, including cancer, diabetes, and neurological conditions. Founded in 2020 and based in Seattle, Talus Bio integrates advanced proteomics, synthetic chemistry, artificial intelligence, and computational biology to engineer and analyze drugs, proteins, and genomics at a

Converge Bio is a pioneering company that integrates Generative AI with biological data to revolutionize drug discovery and development. By leveraging Large Language Models (LLMs) trained on the unique syntax of biological systems, Converge enables biotech and pharmaceutical companies to predict biological outcomes, gain deeper insights, and generate novel molecular candidates. This approach enhances the understanding of complex molecular interactions, signaling pathways, and disease mechanisms,